Believe in Progress
In this episode of Believe in Progress, AACR talks with Lauren C. Leiman, director of BLOODPAC, and Mary Royal, a breast cancer survivor and patient advocate, about liquid biopsy and more.
Listen and Subscribe
In this episode of Believe in Progress, AACR talks with Lauren C. Leiman, director of BLOODPAC, and Mary Royal, a breast cancer survivor and patient advocate, about liquid biopsy and more.
Listen and Subscribe
Cancer is not a single disease, but rather a collection of diseases all characterized by the uncontrolled proliferation of cells.
Learn MoreUnited by Cancer Research: Join with AACR and others to bring awareness to and highlight the importance and impact of cancer research.
Learn MoreAn estimated 24,740 cases of brain and other nervous system cancers are expected to be diagnosed in the United States this year. May is Brain Cancer Awareness Month. Learn more about these cancers.
Learn MoreIrasema Chavez shares her inspiring story about overcoming stomach cancer and breast cancer in the AACR Cancer Disparities Progress Report.
Read Irasema’s StoryUseful information for cancer patients and their families, survivors, caregivers, advocates, and others from Cancer Today magazine.
Learn MoreWhether honoring a special person or a special day, a donation to the American Association for Cancer Research has a lasting impact.
Donate NowThe official news website of the AACR Annual Meeting 2026. Stay up to date on the latest developments from the world’s premier cancer research event.
The AACR Pediatric Cancer Progress Report 2025 highlights the remarkable progress against childhood cancers driven by discoveries across the basic, translational, clinical, and population sciences.
Learn MoreThe AACR and its more than 61,000 members worldwide are advancing a scientifically bold agenda against the collection of diseases we call cancer.
Learn MoreThe AACR Cancer Progress Report 2025 highlights research-driven advances against the collection of often devastating diseases we call cancer.
Learn Morepercent decrease of the overall age-adjusted cancer death rate in the U.S. from 1991 to 2023
Learn Moretherapeutics were approved for new or expanded uses by the FDA from July 1, 2024, to June 30, 2025
Learn Moremillion cancer survivors in the U.S. are living with, through, and beyond their disease thanks to research
Learn MoreYour donation to the American Association for Cancer Research helps our more than 65,000 members worldwide drive progress against cancer.
Donate Now
